Corixa Corporation

Corixa Corporation is a Seattle-based biotechnology company developing a unique approach to vaccine discovery and development. Corixa focuses exclusively on research and development, utilizing broad technology platforms whose components are combined in specific, potent T cell vaccines for the prevention and treatment of cancers and infectious diseases. Corixa offers proprietary advances in three areas of vaccine technology; (1) antigens that trigger an immune response; (2) molecular mechanisms of vaccine delivery, ensuring this response is generated; and (3) adjuvants that encourage and strengthen this response. Corixa follows a partner early and often credo, minimizing cash burn, sharing risk and accelerating this development of new vaccines and diagnostics for cancer and infectious diseases.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Diagnostics
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: